I-Mab Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ALT
Altimmune, Inc. |
$3.91 | $344.64 M | -3.23 | 59 |
ANNX
Annexon, Inc. |
$3.19 | $351.07 M | -2.48 | 106 |
AURA
Aura Biosciences, Inc. |
$6.05 | $375.67 M | -3.12 | 106 |
DMAC
DiaMedica Therapeutics Inc. |
$7.07 | $365.44 M | -10.25 | 27 |
DRTS
Alpha Tau Medical Ltd. |
$4.31 | $365.69 M | -8.96 | 125 |
DSGN
Design Therapeutics, Inc. |
$6.11 | $347.38 M | -6.04 | 56 |
ENGN
enGene Holdings Inc. |
$7.75 | $396.22 M | -4.07 | 56 |
GALT
Galectin Therapeutics Inc. |
$4.33 | $278.62 M | -6.8 | 15 |
|
LBRX
LB Pharmaceuticals Inc Common Stock |
$15.05 | $336.76 M | -1.81 | 16 |
RCKT
Rocket Pharmaceuticals, Inc. |
$3.15 | $340.44 M | -1.3 | 299 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
